Supplementary Figure 1: (a) Schematic representation of N-terminal SFB-p73 and its various deletion mutants (D1 to D6). (b) 293T cells were transfected with SFB-p73 and its deletion constructs along with Myc-WWP2. The site of interaction was determined by pull down with SBP beads followed by immunoblotting with anti-Myc antibody. (c) Schematic representation of N-terminal Myc-WWP2 and its various deletion mutants (D1 to D6). (d) 293T cells were transfected with Myc-WWP2 and its deletion constructs along with HA-p73. The site of
2 interaction was determined by immunoprecipitation with HA antibody followed by immunoblotting with anti-Myc antibody. Figure 2: (a) 293T cells were transfected with Flag-p73, p73 with wild type (WT) WWP2 or catalytically inactive (C/A) WWP2 mutant. 24 hours post transfection cells were treated with MG132 for 6 hours and p73 ubiquitination was detected by immunoblotting with ubiquitin antibody after immunoprecipitation with anti-Flag antibody. (b) HeLa cells were transfected with control shRNA or two individual WWP2 shRNAs. After 24 hours of transfection cells were transfected with HA-p73 construct and 18 hours later cells were treated with MG132 (10uM) for 6hrs before collecting cell lysates. Immunoprecipitation was done using anti-HA followed by immunoblotting with ubiquitin antibody. (c) 293T cells were transfected with SFb-p73 along with HA-tagged ubiquitin mutants. p73 polyubiquitination was detected by denaturing immunoprecipiation with anti-Flag antibody followed by detection with anti-HA (detecting ubiquitin) antibody. hours. The levels of WWP2, WWP1 and PPM1G were detected by immunoblotting with their respective antibodies. (b) HeLa cells were mock treated, cisplatin alone or together with CdCl2 and the percentage of apoptosis was determined by Propidium Iodide staining followed by sub-G1 peak analysis by using flow cytometry. Error bars indicate standard deviation (n=3), P<0.01; students t-test.
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